Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Antitrust/Judiciary Staffer Probes For “Teeth” In GPO Initiative

This article was originally published in The Gray Sheet

Executive Summary

The GPO industry must define penalties for departing from self-imposed ethical standards if group purchasing organizations want to avoid legislation, Senate staffer Seth Bloom suggested May 17

You may also be interested in...



GPO Reform In Offing? Congress Monitors, While Schumer Shifts Stance

Legislative reform of hospital group purchasing organizations has been high on the agenda of some smaller device manufacturers for years. Although progress on Capitol Hill in this direction is slow moving, some in the industry are pointing to an apparent position switch by a key senator recently as a sign that the tide is turning

GPO Reform In Offing? Congress Monitors, While Schumer Shifts Stance

Legislative reform of hospital group purchasing organizations has been high on the agenda of some smaller device manufacturers for years. Although progress on Capitol Hill in this direction is slow moving, some in the industry are pointing to an apparent position switch by a key senator recently as a sign that the tide is turning

MDMA Pushes To Remove Safe Harbor For Group Purchasing Organizations

The Medical Device Manufacturers Association is seeking legislation to repeal the exemption that protects group purchasing organizations (GPOs) from federal anti-kickback laws

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel